CHM 0.00% 2.1¢ chimeric therapeutics limited

Ann: 1st patient treated in ADVENT-AML Phase 1b clinical trial, page-7

  1. 1,583 Posts.
    lightbulb Created with Sketch. 386
    This company needs way more cash though. At the current market cap they really can’t raise what they need without dilution it to nothing.
 
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
(20min delay)
Last
2.1¢
Change
0.000(0.00%)
Mkt cap ! $18.39M
Open High Low Value Volume
2.1¢ 2.1¢ 2.1¢ $9.959K 474.2K

Buyers (Bids)

No. Vol. Price($)
6 1322541 2.0¢
 

Sellers (Offers)

Price($) Vol. No.
2.1¢ 32523 1
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.